Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuantum Data Regulatory News (MAST)

  • There is currently no data for MAST

MED Binding JVA Update

11 Dec 2023 07:52

RNS Number : 3143W
Mast Energy Developments PLC
11 December 2023

Mast Energy Developments PLC

(Incorporated in England and Wales)

(Registration Number: 12886458)

LEI :213800HFVHGJ9YGO9F71

Share code on the LSE: MAST

ISIN: GB00BMBSCV12

('MED' or 'the Company')

Dated: 11 December 2023

Mast Energy Developments PLC ('MED' or 'the Company')

MED Binding Joint Venture Agreement Completion Update

Mast Energy Developments PLC, the UK-based multi-asset owner, developer and operator in the rapidly growing flexible power market, announces that further to its previous announcements dated 23 October 2023, 13 November 2023, and 1 December 2023 respectively, the MED board have received sufficient verbal and written evidence from Proventure as well as its funders that the initial Interim Payment of £2m will be paid to the JV SPV between 15 to around 20 December 2023, subject to signature of definitive agreements. Resultingly, after due and careful consideration, MED has extended the time allowed accordingly for Proventure to remedy its current position and to perform its obligations under the binding JVA.

ENDS

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ('UK MAR'). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

For further information please visit www.med.energy or contact:

Pieter Krügel

Info@med.energy

Mast Energy

Developments PLC

CEO

Jon Belliss

+44 (0)20 7399 9425

Novum Securities

Corporate Broker

Zainab Slemang van Rijmenant

zainab@lifacommunications.com

Lifa Communications

Investor & Media Relations Advisor

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDFFASWFEDSEDE
Date   Source Headline
19th Oct 20227:00 amRNSPyebridge Trading Update
5th Oct 20227:00 amRNSMED Acquires two Projects and Secures Funding
13th Sep 20222:05 pmRNSSecond Price Monitoring Extn
13th Sep 20222:00 pmRNSPrice Monitoring Extension
23rd Aug 20227:00 amRNSHalf-year Report
8th Aug 20229:46 amRNSTR-1: Notification of major holdings
29th Jul 20222:15 pmRNSPartial Settlement Shareholder Loan & Share Issue
13th Jul 202212:46 pmRNSAppointment of Director
5th Jul 20227:00 amRNSPyebridge Trading and Operational Update
20th May 20227:00 amRNSAppointment of Chief Executive Officer
16th May 202211:24 amRNSResults of Annual General Meeting
20th Apr 20227:00 amRNSNotice of AGM
7th Apr 20227:00 amRNSGeneral Update
31st Mar 20227:00 amRNSResults for the 15 month period ended 31 Dec 2021
24th Feb 20227:00 amRNSBordesley T-4 Capacity Market Auction Results
23rd Feb 20222:05 pmRNSSecond Price Monitoring Extn
23rd Feb 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20229:00 amRNSPrice Monitoring Extension
2nd Dec 20212:36 pmRNSMED Share Issue
15th Nov 20217:00 amRNSPyebridge Steady State Operation and Production
20th Oct 20217:00 amRNSTerm Sheet for Project Development Funding Signed
7th Oct 20217:00 amRNSMED Completes Acquisition of Rochdale Power Ltd
1st Oct 20217:00 amRNSNew Board Appointment
2nd Sep 20217:00 amRNSUnaudited results for the 9 months ended June 2021
16th Aug 20217:00 amRNSMED Acquires Third Standby Generation Facility
12th Aug 202112:48 pmRNSPyebridge Correction of Address Particulars
12th Aug 20217:00 amRNSMED acquires 9 MW Pyebridge Facility
30th Jun 20217:00 amRNSAppointment of Joint Broker
10th Jun 20217:00 amRNSBordesley: Construction to Commence
26th May 20219:05 amRNSHalf-year Report
21st May 20217:00 amRNSBordesley Progresses to Construction-ready Status
6th May 20217:00 amRNSOperational Update
14th Apr 20217:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.